Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rei Umezawa

Showing results (41-50 of 140) with videos related to

Pageof 14
Sort By:
Cureus|November 29, 2023
Pre-treatment Evaluation of Patients Eligible for Whole Brain Radiation Therapy: The Risk of Hippocampal Metastases in a Retrospective Study of 248 Cases at a Single InstitutionYojiro Ishikawa, Rei Umezawa, Takaya Yamamoto, et al.
Japanese Journal of Clinical Oncology|December 30, 2016
Elective nodal irradiation is not necessary in chemoradiotherapy for postoperative loco-regional recurrent esophageal cancerKeiichi Jingu, Rei Umezawa, Takaya Yamamoto, et al.
International Cancer Conference Journal|June 7, 2022
Brachytherapy for primary nasal vestibule cancer using Au-198 grainsHinako Harada, Yojiro Ishikawa, Shohei Tanaka, et al.
Esophagus : Official Journal of the Japan Esophageal Society|May 16, 2022
Patterns of failure after salvage chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer: 20-year experience in a single institution in JapanKeiichi Jingu, Rei Umezawa, Takaya Yamamoto, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 3, 2021
Clinical outcomes and prognostic factors for esophageal cancer in patients aged 80 years or older who were treated with definitive radiotherapy and chemoradiotherapyNoriyoshi Takahashi, Rei Umezawa, Keita Kishida, et al.
Acta Oncologica (Stockholm, Sweden)|February 16, 2023
Development and validation of an [<sup>18</sup>F]FDG-PET/CT radiomic model for predicting progression-free survival for patients with stage II - III thoracic esophageal squamous cell carcinoma who are treated with definitive chemoradiotherapyNoriyoshi Takahashi, Shohei Tanaka, Rei Umezawa, et al.
Journal of Radiation Research|November 23, 2023
Current status of remote radiotherapy treatment planning in Japan: findings from a national survey†Masahide Saito, Tetsuro Tamamoto, Shohei Kawashiro, et al.
Scientific Reports|April 30, 2025
Evaluation of deliverable artificial intelligence-based automated volumetric arc radiation therapy planning for whole pelvic radiation in gynecologic cancerYushan Xiao, Shohei Tanaka, Noriyuki Kadoya, et al.
Journal of Radiation Research|July 23, 2013
Evaluation of various deformable image registration algorithms for thoracic imagesNoriyuki Kadoya, Yukio Fujita, Yoshiyuki Katsuta, et al.
Japanese Journal of Clinical Oncology|July 12, 2021
IMRT improves local control in patients with nasopharyngeal carcinoma compared with conventional radiotherapy: propensity score-matched analysisZichang Ma, Rei Umezawa, Takaya Yamamoto, et al.
Pageof 14

Showing results (41-50 of 140) with videos related to

Sort By:
Pageof 14
Cureus|November 29, 2023
Pre-treatment Evaluation of Patients Eligible for Whole Brain Radiation Therapy: The Risk of Hippocampal Metastases in a Retrospective Study of 248 Cases at a Single InstitutionYojiro Ishikawa, Rei Umezawa, Takaya Yamamoto, et al.
Japanese Journal of Clinical Oncology|December 30, 2016
Elective nodal irradiation is not necessary in chemoradiotherapy for postoperative loco-regional recurrent esophageal cancerKeiichi Jingu, Rei Umezawa, Takaya Yamamoto, et al.
International Cancer Conference Journal|June 7, 2022
Brachytherapy for primary nasal vestibule cancer using Au-198 grainsHinako Harada, Yojiro Ishikawa, Shohei Tanaka, et al.
Esophagus : Official Journal of the Japan Esophageal Society|May 16, 2022
Patterns of failure after salvage chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer: 20-year experience in a single institution in JapanKeiichi Jingu, Rei Umezawa, Takaya Yamamoto, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 3, 2021
Clinical outcomes and prognostic factors for esophageal cancer in patients aged 80 years or older who were treated with definitive radiotherapy and chemoradiotherapyNoriyoshi Takahashi, Rei Umezawa, Keita Kishida, et al.
Acta Oncologica (Stockholm, Sweden)|February 16, 2023
Development and validation of an [<sup>18</sup>F]FDG-PET/CT radiomic model for predicting progression-free survival for patients with stage II - III thoracic esophageal squamous cell carcinoma who are treated with definitive chemoradiotherapyNoriyoshi Takahashi, Shohei Tanaka, Rei Umezawa, et al.
Journal of Radiation Research|November 23, 2023
Current status of remote radiotherapy treatment planning in Japan: findings from a national survey†Masahide Saito, Tetsuro Tamamoto, Shohei Kawashiro, et al.
Scientific Reports|April 30, 2025
Evaluation of deliverable artificial intelligence-based automated volumetric arc radiation therapy planning for whole pelvic radiation in gynecologic cancerYushan Xiao, Shohei Tanaka, Noriyuki Kadoya, et al.
Journal of Radiation Research|July 23, 2013
Evaluation of various deformable image registration algorithms for thoracic imagesNoriyuki Kadoya, Yukio Fujita, Yoshiyuki Katsuta, et al.
Japanese Journal of Clinical Oncology|July 12, 2021
IMRT improves local control in patients with nasopharyngeal carcinoma compared with conventional radiotherapy: propensity score-matched analysisZichang Ma, Rei Umezawa, Takaya Yamamoto, et al.
Pageof 14